Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
Top Cited Papers
- 10 April 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 103 (14), 1838-1843
- https://doi.org/10.1161/01.cir.103.14.1838
Abstract
Background—Heparin-induced thrombocytopenia (HIT) is an immune-mediated syndrome caused by heparin. Complications range from thrombocytopenia to thrombocytopenia with thrombosis. We report a prospe...Keywords
This publication has 22 references indexed in Scilit:
- The Pharmacokinetics and Pharmacodynamics of Argatroban: Effects of Age, Gender, and Hepatic or Renal DysfunctionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- Heparin-Induced ThrombocytopeniaJournal of the American College of Cardiology, 1998
- Novastan®(Brand of Argatroban): A Small-Molecule, Direct Thrombin InhibitorSeminars in Thrombosis and Hemostasis, 1997
- A 14-year study of heparin-induced thrombocytopeniaAmerican Journal Of Medicine, 1996
- The epitope specificity of heparin‐induced thrombocytopeniaBritish Journal of Haematology, 1996
- Heparin‐induced thrombocytopenia and thrombosis: clinical and laboratory studiesBritish Journal of Haematology, 1993
- Heparin-induced thrombocytopenia in open heart surgical patients: Sequelae of late recognitionThe Annals of Thoracic Surgery, 1992
- Heparin‐induced thrombocytopenia: mechanism of interaction of the heparin‐dependent antibody with plateletsBritish Journal of Haematology, 1989
- Different platelet specificities of heparin‐dependent platelet aggregating factors in heparin‐associated immune thrombocytopeniaBritish Journal of Haematology, 1986
- Treatment of Heparin-Associated Thrombocytopenia and Thrombosis with Low Molecular Weight Heparin (CY 216)Seminars in Thrombosis and Hemostasis, 1985